clofibrate has been researched along with Fibrosis in 2 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibarra-Lara, L | 1 |
| Sánchez-Aguilar, M | 1 |
| Del Valle-Mondragón, L | 1 |
| Soria-Castro, E | 1 |
| Cervantes-Pérez, LG | 1 |
| Pastelín-Hernández, G | 1 |
| Sánchez-Mendoza, A | 1 |
| Chuppa, S | 1 |
| Liang, M | 1 |
| Liu, P | 1 |
| Liu, Y | 1 |
| Casati, MC | 1 |
| Cowley, AW | 1 |
| Patullo, L | 1 |
| Kriegel, AJ | 1 |
2 other studies available for clofibrate and Fibrosis
| Article | Year |
|---|---|
Clofibrate improves myocardial ischemia-induced damage through regulation of renin-angiotensin system and favours a pro-vasodilator profile in left ventricle.
Topics: Angiotensin II; Animals; Clofibrate; Fibrosis; Heart Ventricles; Male; Myocardial Ischemia; Myocardi | 2020 |
MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.
Topics: Animals; Cardio-Renal Syndrome; Clofibrate; Disease Models, Animal; Fatty Acids; Fibrosis; Gene Expr | 2018 |